Vibmox CV 625 Tablet is a broad-spectrum antibiotic formulation containing Amoxicillin 500 mg, Clavulanic Acid 125 mg, and Lactic Acid Bacillus, designed to provide effective treatment against a wide range of bacterial infections. Amoxicillin works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid protects it from beta-lactamase enzymes, enhancing its effectiveness against resistant bacteria. The addition of Lactic Acid Bacillus helps maintain healthy intestinal flora and supports gastrointestinal well-being during antibiotic therapy. Vibmox CV 625 is indicated for the treatment of Sinusitis, Pneumonia, Bronchitis, Skin and Soft Tissue Infections (SSTI), Intra-abdominal Infections, and other susceptible bacterial infections. With its proven efficacy, reliable absorption, and broad-spectrum coverage, Vibmox CV 625 promotes faster recovery and improved patient outcomes when used under the guidance of a healthcare professional.
